Early Inflammatory Markers Are Independent Predictors of Cardiac Allograft Vasculopathy in Heart-Transplant Recipients
Table 8
CAV: Performance of the Established Model (which uses atherothrombotic markers, only), with the New Model (which adds inflammatory markers to the Established Model).